Paper Details

  1. Home
  2. Paper Details

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trial.

Author: BrierleyJames D, EzzatShereen, GafniAmiram, GoldsteinDavid P, RodinGary, RotsteinLorne, SawkaAnna M, StrausSharon, ThabaneLehana, ThorpeKevin E, TsangRichard W

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

This article discusses the conflicting reports of benefit and the lack of long-term randomized controlled trials for adjuvant radioactive iodine (RAI) treatment after thyroidectomy in patients with early stage papillary thyroid carcinoma (PTC).
Paper Details　
Original Abstract of the Article :
Patients with early stage papillary thyroid carcinoma (PTC), are faced with the decision to either to accept or reject adjuvant radioactive iodine (RAI) treatment after thryroidectomy. This decision is often difficult because of conflicting reports of RAI treatment benefit and medical evidence uncer...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2917435/

データ提供：米国国立医学図書館（NLM）

Decision Aid for Radioactive Iodine Treatment in Early Stage Papillary Thyroid Cancer

This study focuses on the field of oncology, specifically addressing the complex decision-making process faced by patients diagnosed with early stage papillary thyroid carcinoma (PTC). The research investigates the use of a decision aid tool to assist patients in making informed choices regarding adjuvant radioactive iodine (RAI) treatment following thyroidectomy. The study highlights the challenges associated with this decision, particularly the conflicting evidence regarding RAI benefits and the lack of long-term randomized controlled trials. The study emphasizes the need for robust evidence and patient-centered approaches to support decision-making in this context.

Navigating the Uncertainties of Thyroid Cancer Treatment

This study recognizes the difficult choices facing patients with early stage papillary thyroid cancer, particularly when considering the use of adjuvant radioactive iodine (RAI). The study highlights the lack of definitive evidence on the benefits of RAI, making it challenging for patients to make informed decisions. The study emphasizes the need for patient-centered approaches that provide robust evidence to support decision-making.

Informed Decisions for a Healthy Future

This research underscores the importance of providing patients with clear and concise information about their treatment options. This study highlights the need for patient-centered approaches, including decision aid tools, to help patients make informed choices regarding their health. Navigating the uncertainties of thyroid cancer treatment can be a challenging journey, but with access to accurate information and supportive resources, patients can make informed decisions for a healthy future.

Dr.Camel's Conclusion

This research highlights the need for patient-centered approaches to support decision-making in complex medical situations. It emphasizes the importance of providing patients with robust evidence and clear information to enable them to make informed choices about their health. The journey through thyroid cancer treatment can be challenging, but with the right tools and resources, patients can navigate their path with confidence.

Date :
  1. Date Completed 2010-09-29
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

20659341

DOI: Digital Object Identifier

PMC2917435

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.